Total Payments
$432.67
2024 Payments
$24.76
Companies
10
Transactions
16
Medicare Patients
2,066
Medicare Billing
$537,200
Payment Breakdown by Category
Food & Beverage$205.22 (47.4%)
Education$177.45 (41.0%)
Other$50.00 (11.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $205.22 | 12 | 47.4% |
| Education | $177.45 | 3 | 41.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50.00 | 1 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $152.45 | 2 | $0 (2018) |
| Allergan Inc. | $85.38 | 6 | $0 (2018) |
| Bio-Rad Laboratories, Inc. | $50.00 | 1 | $0 (2017) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.34 | 1 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $25.00 | 1 | $0 (2017) |
| ABBVIE INC. | $24.76 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $23.75 | 1 | $0 (2018) |
| Mylan Specialty L.P. | $16.30 | 1 | $0 (2021) |
| EMD Serono, Inc. | $13.64 | 1 | $0 (2017) |
| Mallinckrodt LLC | $12.05 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.76 | 1 | ABBVIE INC. ($24.76) |
| 2021 | $16.30 | 1 | Mylan Specialty L.P. ($16.30) |
| 2019 | $29.34 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($29.34) |
| 2018 | $162.58 | 8 | Allergan Inc. ($85.38) |
| 2017 | $199.69 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($99.00) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/16/2021 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/23/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $29.34 | General |
| 11/06/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/10/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/11/2018 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $53.45 | General |
| 05/08/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/05/2018 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2018 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2017 | Teva Pharmaceuticals USA, Inc. | CINQAIR (Drug) | Education | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 08/09/2017 | Bio-Rad Laboratories, Inc. | Market Research (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $50.00 | General |
| Category: Market Research | ||||||
| 03/30/2017 | EMD Serono, Inc. | Rebif (Biological) | Food and Beverage | Cash or cash equivalent | $13.64 | General |
| Category: Neurology | ||||||
| 03/22/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 642 | 1,128 | $592,373 | $143,220 |
| 2022 | 12 | 541 | 945 | $553,750 | $134,829 |
| 2021 | 9 | 429 | 894 | $497,170 | $126,294 |
| 2020 | 9 | 454 | 885 | $526,365 | $132,857 |
Total Patients
2,066
Total Services
3,852
Medicare Billing
$537,200
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 178 | 460 | $333,688 | $91,633 | 27.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 138 | 260 | $113,104 | $28,831 | 25.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $18,817 | $4,366 | 23.2% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 27 | 28 | $14,085 | $3,497 | 24.8% |
| 76604 | Ultrasound scan of chest | Facility | 2023 | 88 | 129 | $30,475 | $3,290 | 10.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 21 | 31 | $12,362 | $3,164 | 25.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 40 | $11,602 | $2,904 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 22 | $7,049 | $1,907 | 27.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 60 | 69 | $25,988 | $1,543 | 5.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 12 | $3,450 | $968.88 | 28.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 30 | 34 | $15,430 | $696.39 | 4.5% |
| 76705 | Limited ultrasound scan of abdomen | Facility | 2023 | 13 | 16 | $6,324 | $418.34 | 6.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 177 | 431 | $356,206 | $91,107 | 25.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 194 | $70,584 | $18,236 | 25.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 39 | 59 | $28,201 | $6,285 | 22.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 27 | $19,062 | $5,082 | 26.7% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2022 | 18 | 21 | $11,165 | $2,906 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 43 | $10,820 | $2,862 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 35 | $11,582 | $2,688 | 23.2% |
| 76604 | Ultrasound scan of chest | Facility | 2022 | 62 | 75 | $21,119 | $1,983 | 9.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $5,322 | $1,455 | 27.3% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 14 | 14 | $8,245 | $1,183 | 14.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 22 | 23 | $8,842 | $528.76 | 6.0% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 12 | 12 | $2,602 | $512.17 | 19.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 164 | 361 | $297,325 | $77,119 | 25.9% |
About Dr. Javed Iqbal, MD
Dr. Javed Iqbal, MD is a Pulmonary Disease healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841391737.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Javed Iqbal, MD has received a total of $432.67 in payments from pharmaceutical and medical device companies, with $24.76 received in 2024. These payments were reported across 16 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($205.22).
As a Medicare-enrolled provider, Iqbal has provided services to 2,066 Medicare beneficiaries, totaling 3,852 services with total Medicare billing of $537,200. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Bronx, NY
- Active Since 09/26/2006
- Last Updated 02/18/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841391737
Products in Payments
- OFEV (Drug) $99.00
- AVYCAZ (Drug) $57.24
- Market Research (Device) $50.00
- NAMZARIC (Drug) $28.14
- CINQAIR (Drug) $25.00
- TEFLARO (Drug) $24.76
- UTIBRON (Drug) $23.75
- YUPELRI (Drug) $16.30
- Rebif (Biological) $13.64
- ACTHAR (Biological) $12.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Bronx
Dr. Raji Ayinla, M.d, M.D
Pulmonary Disease — Payments: $699,684
Pulmonary Disease $699,684
Peter Dicpinigaitis, Md, MD
Pulmonary Disease — Payments: $305,607
Pulmonary Disease $305,607
Neomi Shah, M.d, M.D
Pulmonary Disease — Payments: $16,397
Pulmonary Disease $16,397
Richard Deluca, M.d, M.D
Pulmonary Disease — Payments: $14,463
Pulmonary Disease $14,463
Dr. Samuel Deleon, M.d, M.D
Pulmonary Disease — Payments: $11,703
Pulmonary Disease $11,703
Dr. Manuel Cabrera, Md, MD
Pulmonary Disease — Payments: $7,790
Pulmonary Disease $7,790